title: Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
authors.forename: M
authors.initials: M
authors.lastname: Zink
authors.forename: S
authors.initials: S
authors.lastname: Englisch
authors.forename: U
authors.initials: U
authors.lastname: Knopf
authors.forename: A
authors.initials: A
authors.lastname: Kuwilsky
authors.forename: H
authors.initials: H
authors.lastname: Dressing
mesh_terms: D000328:Adult; D018692:Antimanic Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced* / Q000188:drug therapy* / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D014635:Valproic Acid / Q000627:therapeutic use*
chemical_list: D018692:Antimanic Agents; D014150:Antipsychotic Agents; D014635:Valproic Acid; D003024:Clozapine